Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 4, 2005 - Issue 4
Submit an article Journal homepage
1,042
Views
37
CrossRef citations to date
0
Altmetric
Review

Drug use and breastfeeding

Kenneth F Ilett University of Western Australia, Pharmacology Unit, School of Medicine and Pharmacology, Crawley, 6009, Australia. [email protected]; The Western Australian Centre for Pathology and Medical Research, Clinical Pharmacology and Toxicology Laboratory, Nedlands, 6009, Australia
&
Judith H Kristensen King Edward Memorial and Princess Margaret Hospitals, Pharmacy Department, Women’s and Children’s Health Service, Subiaco, 6008, Australia
Pages 745-768 | Published online: 12 Jul 2005

Bibliography

  • WRENCE RA, LAWRENCE RM: Breastfeeding in modern medicine. In: Breastfeeding a guide for the medical profession. Lawrence RA, Lawrence RIVI (Ed.), Mosby, St Louis USA (1999):1–34.
  • LAWRENCE RA, LAWRENCE RM: Biochemistry of human milk. In: Breastfeeding a guide for the medical profession. Lawrence RA, Lawrence RIVI (Ed.), Mosby, St Louis USA (1999):95–158.
  • LAWRENCE RM: Host-resistance factors and immunologic significance of human milk. In: BreasilCeding; a guide for the medical profession. Lawrence RA, Lawrence RM (Ed.), Mosby, St Louis USA (1999):159–195.
  • DUNCAN B, EY J, HOLBERG CJ, WRIGHT AL, MARTINEZ FD, TAUSSIG LM: Exclusive breast-feeding for at least 4 months protects against otitis media. Pediatrics (1993) 91(5):867–872.
  • LAWRENCE RA, LAWRENCE RM: Making an informed decision about breastfeeding. In: BreastiCeding a guide for the medical profession. Lawrence RA, Lawrence RM (Ed.), Mosby, St Louis USA (1999):217–231.
  • LAWRENCE RA, LAWRENCE RM: Psychological impact of breastfeeding. In: Breastfeeding a guide for the medical profession. Lawrence RA, Lawrence RIVI (Ed.), Mosby, St Louis USA (1999):197–216.
  • LAWRENCE RA, HOWARD CR: Given the benefits of breastfeeding, are there any contraindications? Clinics Perinatol (1999) 26(2):479–90, viii.
  • HALE TW, ILETT KF: In: Drug therapy and breastfeeding. From theory to clinical practice. The Parthenon Publishing Group, London (2002):1–94.
  • NARANJO CA, BUSTO U, SELLERS EM et al.: A method for estimating the probability of adverse drug reactions. Pharmacol Ther. (1981) 30(2):239–245.
  • ANDERSON PO, POCHOP SL, MANOGUERRA AS: Adverse drug reactions in breastfed infants: less than imagined. Clin. Pediat. (Phila.). (2003) 42(4):325–340.
  • ••Balanced evaluation of adversedrug events in the breastfed infant.
  • ASSELIN BL, LAWRENCE RA: Maternal disease as a consideration in lactation management. Clinics Perinatol (1987) 14(0:71–87.
  • LAWRENCE RA, LAWRENCE RM: Physiology of lactation. In: Breastleeding. A guide for the medical profession. Fathman EM (Ed.), Mosby, St Louis, MS, USA (1999)59–94.
  • HENNART P, DELOGNE-DESNOECK J, VIS H, ROBYN C: Serum levels of prolactin and milk production in women during a lactation period of thirty months. OM Endocrinol. (Oxf). (1981) 14(4):349–353.
  • PEAKER M, WILDE CJ: Feedback control of milk secretion from milk. J. Mammary Gland Biol. Neoplasia (1996) 1(3):307–315.
  • HORSEMAN ND: Prolactin. In: Hypothalamic Control of Prolactin Synthesis and Secretion. Ben-Johnathan N (Ed.), Kluwer Academic Publishers, City, USA (2000:1–24.
  • KROPP S, ZIEGENBEIN M, GROHMANN R, ENGEL RR, DEGNER D: Galactorrhea due to psychotropic drugs. Pharmacopsychiatry (2004) 37\(Suppl. 1):584–588.
  • HOFMEYR GJ, VAN IDDEKINGE B: Domperidone and lactation. Lancet (1983) 1(8325):647.
  • BLANK C, EATON V, BENNETT J, JAMES SL: A double blind RCT of domperidone and metoclopramide as pro-lactational agents in mothers of preterm infants. Perinatal Socie0 of Australia and New Zealand 5th Annual Conference. Canberra, Australia (2000:73.
  • DA SILVA OP, KNOPPERT DC, ANGELINI MM, FORRET PA: Effect of domperidone on milk production in mothers of premature newborns: a randomized, double-blind, placebo-controlled trial. Can. Med. Ass. J. (2001) 164(1):17–21.
  • PETRAGLIA F, DE L, V, SARDELLI S, PIERONI ML, D'ANTONA N, GENAZZANI AR: Domperidone in defective and insufficient lactation. Eur. I Obstet. Cynecol Reprod. Biol. (1985) 19(5):281–287.
  • DOONGAJI DR, SHETH AS, DESAI AB et al: Use of metoclopramide in the differential diagnosis of drug-induced involuntary movements. ./. Postgrad. Med. (1982) 28(2):101–106.
  • BRIGGS GG, FREEMAN RK, YAFFE SJ: Metoclopramide. In: Drugs in pregnancy and lactation. Briggs GG, Freeman RK, Yaffe SJ (Ed.), Lippincott Williams and Wilkins, Philadelphia (2002)910/m–915/m.
  • COMMITTEE ON DRUGS: American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics (1994) 93:137–150.
  • NEWMAN J, PITMAN T: Not enough milk. In: The Ultimate Breastfeeding Book of Answers. Prima Publishing, Roseville, CA (2000):69–121.
  • ANONYMOUS: Maxolon, MIMS Abbreviated Prescribing Information. E-MIMS Version 5.00.0106 MediMedia Australia Pty Ltd St Leonards, Australia (2005).
  • DROLET B, ROUSSEAU G, DALEAU P, CARDINAL R, TURGEON J: Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation (2000) 102(16):1883–1885.
  • RODEN DM: Drug-induced prolongation of the QT interval. New Engl. I Med. (2004) 350(10):1013–1022.
  • HEYKANTS J, HENDRIKS R, MEULDERMANS W, MICHIELS M, SCHEYGROND H, REYNTJENS H: On the pharmacokinetics of domperidone in animals and man. IV. The pharmacokinetics of intravenous domperidone and its bioavailability in man following intramuscular, oral and rectal administration. Eur. I Drug Metab. Pharmacokin. (1981) 6(1):61–70.
  • ANONYMOUS: Motilium, MIMS Abbreviated Prescribing Information. E-MIMS Version 5.00.0106 MediMedia Australia Pty Ltd St Leonards, Australia (2005).
  • DA SILVA OP, KNOPPERT DC: Domperidone for lactating women. Can. Med. Ass. J. (2004) 171(7):725–726.
  • HOFMEYR GJ, VAN IDDEKINGE B, BLOTT JA: Domperidone: secretion in breast milk and effect on puerperal prolactin levels. BE Obstet. Cynaecol (1985) 92(2):141–144.
  • WAN W-Z: Domperidone; defining an effective dose schedule as a stimulant of milk production. Postgraduate Diploma in Pharmacology, School of Medicine and Pharmacology, University of Western Australia. (2004) :1–86.
  • NEVILLE MC, WALSH CT: Effects of xenobiotics on milk secretion and composition. Am. J. Clin. Nutr. (1995) 61(3 Suppl.):687S–694S.
  • IFFY L, O'DONNELL J, CORREIA J, HOPP L: Severe cardiac dysrhythmia in patients using bromocriptine postpartum. Am. J. Ther. (1998) 5(2):111–115.
  • POP C, METZ D, MATEI M, WAGNER E, TASSAN S, ELAERTS J: Postpartum myocardial infarction induced by Parlodel. Arch. Mal. Coeur. Vaiss. (1998) 91(9):1171–1174.
  • DUTT S, WONG F, SPURWAY JH: Fatal myocardial infarction associated with bromocriptine for postpartum lactation suppression. Aust. N Z Obstet. Cynaecol (1998) 38(1):116–117.
  • WEBSTER J: A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation [published erratum appears in Drug Saf. (1996) 14(5):342.Drug Sal: (1996) 14(4):228–238.
  • O'SHEA E: Safety of medications in lactation cessation [letter] [see comments]. Can. Fain. Physician. (1996) 42:616.
  • FERRARI C, PISCITELLI G, CROSIGNANI PG: Cabergoline: a new drug for the treatment of hyperprolactinaemia. Hum. Reprod. (1995) 10(7):1647–1652.
  • WEBSTER J, PISCITELLI G, POLLI A et al.: The efficacy and tolerability of long-term cabergoline therapy in hyperprolactinaemic disorders: an open, uncontrolled, multicentre study. European Multicentre Cabergoline Study Group. Clin. Endocrinol (Oki). (1993) 39(3):323–329.
  • ANONYMOUS: Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomised, double blind, multicentre study. European Multicentre Study Group for Cabergoline in Lactation Inhibition [see comments]. BE Med. J. (1991) 302(6789):1367–1371.
  • CABALLERO-GORDO A, LOPEZ-NAZARENO N, CALDERAY M, CABALLERO JL, MANCHENO E, SGHEDONI D: Oral cabergoline. Single-dose inhibition of puerperal lactation. J. Reprod. Med. (1991) 36(10):717–721.
  • BOOKER DE, PAHL IR, FORBES DA: Control of postpartum breast engorgement with oral contraceptives. II. Am. J. Obstet. Cynecol (1970) 108(2):240–242.
  • GAMBRELL RDJ: Immediate postpartum oral contraception. Obstet. Cynecol (1970) 36(1):101–106.
  • BOOKER DE, PAHL IR: Control of postpartum breast engorgement with oral contraceptives. Am. J. Obstet. Cynecol (1967) 98(8):1099–1101.
  • ALJAZAF K, HALE TW, ILETT KF et al.: Pseudoephedrine - effects on milk production in women and estimation of infant exposure via breastmilk. BL J. Clin. Pharmacol (2003) 56:18–24.
  • HEALY M: Suppressing lactation with oral diuretics. Lancet (1961) 1:1353–1354.
  • PHELPS DL, KARIM Z: Spironolactone: relationship between concentrations of dethioacetylated metabolite in human serum and milk. J. Pharm. Li. (1977) 66(8):1203.
  • MILLER ME, COHN RD, BURGHART PH: Hydrochlorothiazide disposition in a mother and her breast-fed infant. J. Pediatr. (1982) 101(5):789–791.
  • RAMPONO J, KRISTENSEN JH, HACKETT LP, PAECH M, KOHAN R, ILETT KF: Citalopram and demethylcitalopram in human milk; distribution, excretion and effects in breast fed infants. Br. J. Cliii. Pharmacol (2000) 50(10):263–268.
  • KRISTENSEN JH, ILETT KF, HACKETT LP, YAPP P, PAECH M, BEGG EJ: Distribution and excretion of fluoxetine and norfluoxetine in human milk. Br. J. Cliii. Pharmacol (1999) 48:521–527.
  • ILETT KF, LEBEDEVS TH, WOJNAR-HORTON RE et al: The excretion of dothiepin and its primary metabolites in breast milk. Br. .1 Cliii. Pharmacol (1992) 33(6):635–639.
  • BEGG EJ, ATKINSON HC: Modelling of the passage of drugs into milk. Pharmacol Ther. (1993) 59(3):301–310.
  • ATKINSON HC, BEGG EJ: Prediction of drug distribution into human milk from physicochemical characteristics. Clin. Pharmacokinet. (1990) 18(2):151–167.
  • FLEISHAKER JC, DESAI N, MCNAMARA PJ: Factors Affecting the Milk-To-Plasma Drug Concentration Ratio in Lactating Women - Physical Interactions with Protein and Fat. J. Pharm. Sci. (1987) 76(3):189–193.
  • FLEISHAKER JC: Models and methods for predicting drug transfer into human milk. Adv. Drug Deify. Rev (2003) 55(5):643–652.
  • ITO S, LEE A: Drug excretion into breast milk - Overview. Adv. Drug Deify. Rev (2003) 55(5):617–627.
  • AGATONOVIC-KUSTRIN A, TUCKER IG, ZECEVIC M, ZIVANOVIC LJ: Prediction of drug transfer into human milk from theoretically derived descriptors [Review]. Anal. Chim. Acta. (2000) 418(2):181–195.
  • GERK PM, KUHN RJ, DESAI NS, MCNAMARA PJ: Active transport of nitrofurantoin into human milk. Pharmacotherapy (2001) 21(6):669–675.
  • GERK PM, 00 CY, PAXTON EW, MOSCOW JA, MCNAMARA PJ: Interactions between cimetidine, nitrofurantoin, and probenecid active transport into rat milk. .1 Pharmacol Exp. Ther. (2001) 296(1):175–180.
  • KARI FW, WEAVER R, NEVILLE MC: Active transport of nitrofurantoin across the mammary epithelium in vivo. J. Pharmacol Exp. Ther. (1997) 280(2):664–668.
  • TODDYWALLA VS, KARI FW, NEVILLE MC: Active transport of nitrofurantoin across a mouse mammary epithelial monolayer. I Pharmacol Exp. Ther. (1997) 280(2):669–676.
  • GERK PM, MOSCOW JA, MCNAMARA PJ: Basolateral active uptake of nitrofurantoin in the CIT3 cell culture model of lactation. Drug Metab. Dispos. (2003) 31(6):691–693.
  • MERINO G, JONKER JW, WAGENAAR E, VAN HERWAARDEN AE, SCHINKEL AH: The Breast Cancer Resistance Protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion and milk secretion of the antibiotic nitrofurantoin. Mol Pharmacol (2005)
  • CY, KUHN RJ, DESAI N, MCNAMARA PJ: Active transport of cimetidine into human milk. Clin. Pharmacol Ther. (1995) 58(5):548–555.
  • LAU RJ, EMERY MG, GALINSKY RE: Unexpected accumulation of acyclovir in breast milk with estimation of infant exposure. Obstet. Cynecol (1987) 69(3 Pt 2):468–471.
  • BORK K, KAISER T, BENES P: Transfer of aciclovir from plasma to human breast milk. Armeimittelforsch (2000) 50(7):656–658.
  • ITO S, ALCORN J: Xenobiotic transporter expression and function in the human mammary gland. Adv. Drug Deify. Rev (2003) 55(5):653–665.
  • ALCORN J, LU X, MOSCOW JA, MCNAMARA PJ: Transporter gene expression in lactating and nonlactating human mammary epithelial cells using real-time reverse transcription-polymerase chain reaction. J. Pbarmacol Exp. Titer. (2002) 303(2):487–496.
  • ••Good review of the small but developingarea of active transporters in drug transfer into milk.
  • HALE TW, KRISTENSEN JH, HACKETT LP, KOHAN R, ILETT KF: Transfer of metformin into human milk. Diabetologia (2002) 45(11):1509–1514.
  • GARDINER SJ, KIRKPATRICK CMJ, BEGG EJ, ZHANG M, MOORE MP, SAVILLE DJ: Transfer of metformin into human milk. Clin. Pbarmacol. Titer. (2003) 73(1):71–77.
  • BEGG EJ, ATKINSON HC, DUFFULL SB: Prospective evaluation of a model for the prediction of milk:plasma drug concentrations from physicochemical characteristics. BE J. Clin. Pbarmacol (1992) 33(5):501–505.
  • HALE TW: Maternal medications during breastfeeding. Clin. Obstet. Gynecol (2004) 47(3):696–711.
  • BEGG EJ: In: Instant Clinical Pharmacology Blackwell Publishing Ltd, Oxford, UK (2003):34–35.
  • ATKINSON HC, BEGG EJ: Prediction of drug distribution into human milk from physicochemical characteristics. Pbarmacokinet. (1990) 18(2):151–167.
  • HALE TW: In: Medications and mothers' milk. Pharmasoft Publishing, Amarillo,TX,USA (2004):1–938.
  • BENNETT PN: Use of the monographs on drugs. In: Drugs and Human Lactation. Bennett PN (Ed.), Elsevier, Amsterdam (1996):67–74.
  • BEGG EJ, DUFFULL SB, HACKETT LP, ILETT KF: Studying drugs in human milk: time to unify the approach. J. Hum. Lact. (2002) 18(4):319–328.
  • ••Illustrates best practice for design andanalysis for studies of drugs and human milk.
  • ASTRUP-JENSEN A, BATES CJ, BEGG EJ et al: In: Drugs and Human Lactation. Bennett, P N. (Ed.), Elsevier, Amsterdam (1996).
  • BRIGGS GG, FREEMAN RK, YAFFE SJ: In: Drugs in pregnancy, and lactation. Briggs, G. G., Freeman, R. K., and Yaffe, S. J. (Ed.), Lippincott Williams and Wilkins, Philadelphia (2002).
  • ANONYMOUS: In: Drugs and breastfeeding. Pharmacy Department (Ed.), Royal Women's Hospital, Melbourne (2004).
  • ANONYMOUS: Drug use in pregnancy and breastfeeding. In: eTG Complete. Therapeutic Guidelines Limited, North Melbourne, Australia (2005).
  • SPIGSET 0, HAGG S: Analgesics and breast-feeding: safety considerations. Paediatr. Drugs (2000) 2(3):223–238.
  • DAVIS JM, BHUTARI VK: Neonatal apnea and maternal codeine use. Periatc Res. (2005) 19(4):170A.
  • PAECH M, KRISTENSEN J, ILETT KF: Nonsteroidal antiinflammatory drugs during lactation [letter; comment]. Arresth. Analgesia (1998) 87(4):977.
  • HALE TW, MCDONALD R, BOGER J: Transfer of celecoxib into human milk. J. Hum. Lact. (2004) 20(4):397–403.
  • OSTREA EM, CHAVEZ CJ, STRAUSS ME: A study of factors that influence the severity of neonatal narcotic withdrawal. I. Pediatr. (1976) 88(4 Pt. 1):642–645.
  • STRAUSS ME, ANDRESKO M, STRYKER JC, WARDELL JN, DUNKEL LD: Methadone maintenance during pregnancy: pregnancy, birth, and neonate characteristics. Am. I Obstet. Gynecol (1974) 120(7):895–900.
  • MALPAS TJ, DARLOW BA: Neonatal abstinence syndrome following abrupt cessation of breastfeeding. N Z Medi: (1999) 112(1080):12–13.
  • MALPAS TJ, DARLOW BA, LENNOX R, HORWOOD LJ: Maternal methadone dosage and neonatal withdrawal. Aust. N Z Obstet. Gynaecol (1995) 35(2):175–177.
  • CHAN CF, PAGE-SHARP M, KRISTENSEN JH, O'NEIL G, ILETT KF: Transfer of naltrexone and its metabolite 6,beta-naltrexol into human milk. J. Hum. Lact. (2004) 20(3):322–326.
  • MARQUET P, CHEVREL J, LAVIGNASSE P, MERLE L, LACHATRE G:Buprenorphine withdrawal syndrome in a newborn. Clin. Pbarmacol Titer. (1997) 62(5):569–571.
  • HIROSE M, HOSOKAWA T, TANAKA Y: Extradural buprenorphine suppresses breast feeding after caesarean section. Br. J. Anaesth. (1997) 79(1):120–121.
  • HAGG S, SPIGSET 0: Anticonvulsant use during lactation. Drug Sal (2000) 22 (6) :425–440.
  • PENNELL PB: Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology (2003) 61(6):S35–S42.
  • CHAUDRON LH, JEFFERSON JW: Mood stabilizers during breastfeeding: A review J. Clin. Psychiatry (2000) 61(2):79–90.
  • RUBIN ET, LEE A, ITO S: When breastfeeding mothers need CNS-acting drugs. Can. J. Clin. Pbarmacol (2004) 11(2):e257–e266.
  • STAHL MMS, NEIDERUD J, VINGE E: Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid. Pediatc (1997) 130(6):1001–1003.
  • OHMAN I, VITOLS S, TOMSON T: Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia (2000) 41(6):709–713.
  • OHMAN I, VITOLS S, LUEF G, SODERFELDT B, TOMSON T: Topiramate kinetics during delivery, lactation, and in the neonate: Preliminary observations. Epilepsia (2002) 43(10):1157–1160.
  • ••Robust study design and executioncovering infant exposure in both pregnancy and lactation.
  • KRAMER G, HOSLI I, GLANZMANN R, HOLZGREVE W: Levetiracetam accumulation in breast milk. Epilepsia. (2002) 43\(Suppl. 7):105.
  • MATHESON I, LUNDE PK, BREDESEN JE: Midazolam and nitrazepam in the maternity ward: milk concentrations and clinical effects. Br. J. Clin. Pbarmacol (1990) 30(6):787–793.
  • LEBEDEVS TH, WOJNAR-HORTON RE, YAPP P et al.: Excretion of temazepam in breast milk [letter]. BE J. Clin. Pbarmacol (1992) 33(2):204–206.
  • FOMINA PI: Untersuchungen uber den Ubergang des aktiven agens des chungen uber den Ubergang des aktiven agens des Muttrkorns in die mulch. Arch. Biochem. Biophys. (1934) 157:275–277.
  • VORHERR H: Contraindications to breast-feeding. JAMA (2005) 227:676.
  • BAR-OZ B, BULKOWSTEIN M, BENYAMINI L et al.: Use of antibiotic and analgesic drugs during lactation. Drug Sal: (2003) 26(13):925–935.
  • •Useful review of antibiotics and analgesics in breastfeeding.
  • MATSUDA S: Transfer of antibiotics into maternal milk. Biol. Res. Pregnancy Perinatol (1984) 5(2):57–60.
  • SORENSEN HT, SKRIVER MV, PEDERSEN L, LARSEN H, EBBESEN F, SCHONHEYDER HC: Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides. Scand. J. Infect. Dis. (2003) 35(2):104–106.
  • STANG H: Pyloric stenosis associated with erythromycin ingested through breastmilk. Minn. Med. (1986) 69(10:669–670.
  • ANONYMOUS: In: Paediatric Pharmacopeia. Kemp, C. A. and McDowell, J. M. (Ed.), Pharmacy Department, Royal Melbourne Children's Hospital, Melbourne (2002).
  • GHAFFER F, MCCRAKEN GH: Quinolones in pediatrics. In: Quinolone antimicrobial agnets. Hoper DC, Rubenstein E (Ed.), ASM Press, Washington DC, USA (2003)343–354.
  • HARMON T, BURKHART G, APPLEBAUM H: Perforated pseudomembranous colitis in the breast-fed infant. J. Pediatr. Surg. (1992) 27(6):744–746.
  • COMMITTEE ON DRUGS: American Academy of Pediatrics. Transfer of drugs and other chemicals into human milk. Pediatrics. (2001) 108(3):776–789.
  • YOUNG TE, MANGUM B: In: Neofax; A Manual of Drugs Used in Neonatal Care. Acorn Publishing Inc, Raleigh, NC, USA (2003).
  • ROTHERMEL P, FABER M: Drugs in breastmilk: a consumer's guide. Birth Fam. J. (1975) 2:76–78.
  • KAUFMAN D, BOYLE R, HAZEN KC, PATRIE JT, ROBINSON M, DONOWITZ LG: Fluconazole prophylaxis against fungal colonization and infection in preterm infants. New Engl. J. Med. (2001) 345(23):1660–1666.
  • MEYER LJ, DE MIRANDA P, SHETH N, SPRUANCE S: Acyclovir in human breast milk. Am. J. Obstet. Cynecol (1988) 158(3 Pt 1):586–588.
  • TADDIO A, KLEIN J, KOREN G: Acyclovir excretion in human breast milk. Annals Pharmacother. (1994) 28(5):585–587.
  • CELILOGLU M, CELIKER S, GUVEN H, TUNCOK Y, DEMIR N, ERTEN 0: Gentamicin excretion and uptake from breast milk by nursing infants. Obstet. Cynecol (1994) 84(2):263–265.
  • AZIZI F: Effect of methimazole treatment of maternal thyrotoxicosis on thyroid function in breast-feeding infants. Pediam (1996) 128(6):855–858.
  • AZIZI F, KHOSHNIAT M, BAHRAINIAN M, HEDAYATI M: Thyroid function and intellectual development of infants nursed by mothers taking methimazole. j Clin. Endocrinol Metab. (2000) 85(9):3233–3238.
  • LAMBERG BA, IKONEN E, OSTERLUND K et al: Antithyroid treatment of maternal hyperthyroidism during lactation. Clin. Endocrinol (Oxf). (1984) 21(1):81–87.
  • RYLANCE GW, WOODS CG, DONNELLY MC, OLIVER JS, ALEXANDER WD: Carbimazole and breastfeeding. Lancet (1987) 1(8538):928.
  • COOPER DS: Antithyroid drugs: to breast-feed or not to breast-feed. Am. J. Obstet. Cynecol (1987) 157(2):234–235.
  • KAMPMANN JP, JOHANSEN K, HANSEN JM, HELWEG J: Propylthiouracil in human milk. Revision of a dogma. Lancet (1980) 1(8171):736–737.
  • ANDERSON PO: Drugs and breast feeding. Semi'. Perinatol (1979) 3(3):271–278.
  • GREENBERGER PA, ODEH YK, FREDERIKSEN MC, ATKINSON AJ: Pharmacokinetics of prednisolone transfer to breast milk. Clin. Pharmacol Ther. (1993) 53(3):324–328.
  • OST L, WETTRELL G, BJORKHEM I, RANE A: Prednisolone excretion in human milk. J. Pediatr. (1985) 106(6):1008–1011.
  • KENNEDY KI, SHORT RV, TULLY MR: Premature introduction of progestin-only contraceptive methods during lactation. Contraception (1997) 55(6):347–350.
  • ANONYMOUS: Depo-Provera, MIMS Abbreviated Prescribing Information. E-MIMS Version 5.00.0106 MediMedia Australia Pty Ltd St Leonards, Australia (2005).
  • SHAABAN MM: Contraception with progestogens and progesterone during lactation. J. Steroid Biochem. Mol (1991) 40(4-6):705–710.
  • SHAABAN MM, SALEM HT, ABDULLAH KA: Influence of levonorgestrel contraceptive implants, Norplantr, initiated early postpartum upon lactation and infant growth. Contraception (1985) 32(6):623–635.
  • O'HARA MW, ZEKOSKI EM, PHILIPPS LH, WRIGHT EJ: Controlled prospective study of postpartum mood disorders: comparison of childbearing and nonchildbearing women. J. Abnorm. Psycho]. (1990) 99(1):3–15.
  • SINCLAIR D, MURRAY L: Effects of postnatal depression on children's adjustment to school. Teacher's reports. Br. J. Psychiatry (1998) 172:58-63:58–63.
  • ZEKOSKI EM, O'HARA MW, WILLS KE: The effects of maternal mood on mother-infant interaction. J. Abnorm. Child Psycho]. (1987) 15(3):361–378.
  • LEE CM, GOTLIB IH: Adjustment of children of depressed mothers: a 10-month follow-up. J. Abnorm. Psycho]. (1991) 100(0473–477.
  • MURRAY L, FIORI-COWLEY A, HOOPER R, COOPER P: The impact of postnatal depression and associated adversity on early mother-infant interactions and later infant outcome. Child Dev. (1996) 67(5):2512–2526.
  • BUIST A, JANSON H: Effect of exposure to dothiepin and northiaden in breast milk on child development. BE J. Psychiatry (1995) 167(3):370–373.
  • NULMAN I, ROVET J, STEWART DE et al: Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am. J. Psychiatry (2002) 159(11):1889–1895.
  • NULMAN I, ROVET J, STEWART DE et al: Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl. J. Med. (1997) 336(4):258–262.
  • HEIKKINEN T, EKBLAD U, KERO P, EKBLAD S, LAINE K: Citalopram in pregnancy and lactation. Clin. Pharmacol Ther. (2002) 72(2):184–191.
  • HEIKKINEN T, EKBLAD U, PALO P, LAINE K: Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation. Clin. Pharmacol Ther. (2003) 73(4):330–337.
  • ADRAC COMMITTEE: Maternal SSRI use and neonatal effects. Aust. Adverse Drug React. Bull. (2003) 22(3):1–3.
  • LESTER BM, CUCCA J, ANDREOZZI L, FLANAGAN P, OH W: Possible association between fluoxetine hydrochloride and colic in an infant. J. Am. Acad. Child Adolesc. Psychiatry (1993) 32(6):1253–1255.
  • MOHAN CG, MOORE JJ: Fluoxetine toxicity in a preterm infant. J. Perinatol (2000) 20(7):445–446.
  • MHANNA MJ, BENNET JB, IZATT SD: Potential fluoxetine chloride (Prozac) toxicity in a newborn. Pediatrics. (1997) 100(1):158–159.
  • KRISTENSEN JH, ILETT KF, DUSCI LJ et al.: Distribution and excretion of sertraline and N-desmethylsertraline in human milk. Br. I Clin. Pharmacol (1998) 45(5):453–457.
  • STOWE ZN, OWENS MJ, LANDRY JC et al.: Sertraline and desmethylsertraline in human breast milk and nursing infants [see comments]. Am. J. Psychiatry (1997) 154(9):1255–1260.
  • ALTSHULER LL, BURT VK, MCMULLEN M, HENDRICK V: Breastfeeding and sertraline: a 24-hour analysis. .1 Clin. Psychiatry (1995) 56(6):243–245.
  • HENDRICK V, FUKUCHI A, ALTSHULER L, WIDAWSKI M, WERTHEIMER A, BRUNHUBER MV: Use of sertraline, paroxetine and fluvoxamine by nursing women. BE J. Psychiatry (2001) 179:163–166.
  • MAMMEN OK, PEREL JM, RUDOLPH G, FOGLIA JP, WHEELER SB: Sertraline and norsertraline levels in three breastfed infants. J. Clin. Psychiatry (1997) 58(3):100–103.
  • WISNER KL, PEREL JM, BLUMER J: Serum sertraline and N-desmethylsertraline levels in breast-feeding mother-infant pairs. Am. J. Psychiatry (1998) 155(5):690–692.
  • EPPERSON N, CZARKOWSKI KA, WARD-O'BRIEN D et al: Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs. Am. .1 Psychiatry (2001) 158(10):1631–1637.
  • ILETT KF, HACKETT LP, KRISTENSEN JH, RAMP ONO J, KOHAN R: Estimation of infant dose and assessment of breastfeeding safety for escitalopram use in postnatal depression. Proceedings of the 9th International Congress of Ther. Drug Monit. and Clinical Toxicology Louisville, KY, USA (2005).
  • ILETT KF, HACKETT LP, DUSCI LJ et al: Distribution and excretion of venlafaxine and 0-desmethylvenlafaxine in human milk. BE I Clin. Pharmacol (1998) 45(5):459–462.
  • ILETT KF, KRISTENSEN JH, HACKETT LP, PAECH M, KOHAN R, RAMPONO J: Distribution of venlafaxine and its 0-desmethyl metabolite in human milk and their effects in breastfed infants. Br. J. Clin. Pharmacol (2002) 53(1):17–22.
  • ••Example of robust experimental design instudies of drug transfer into human milk.
  • GENTILES: Clinical utilization of atypical antipsychotics in pregnancy and lactation. Annals Pharmacother. (2004) 38(7-8):1265–1271.
  • GARDINER SJ, KRISTENSEN JH, BEGG EJ et al.: Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants. Am. Psychiatry (2003) 160(8):1428–1431.
  • CROKE S, BUIST A, HACKETT LP, ILETT KF, NORMAN T, BURROWS GD: Olanzapine excretion in human breast milk: estimation of infant exposure. Int. J. Neuropsychopharmacol (2002) 5(3):243–247.
  • ILETT KF, HACKETT LP, KRISTENSEN JH, VADDADI KS, GARDINER SJ, BEGG EJ: Transfer of risperidone and 9-hydroxyrisperidone into human milk. Annals Pharmacother. (2004) 38(2):273–276.
  • RATNAYAKE T, LIBRETTO SE: No complications with risperidone treatment before and throughout pregnancy and during the nursing period. Psychiatry (2002) 63(1):76–77.
  • HILL RC, MCI VOR RJ, WOJNAR-HORTON RE, HACKETT LP, ILETT KF: Risperidone distribution and excretion into human milk: case report and estimated infant exposure during breast-feeding [letter]. J. Clin. Psychopharmacol (2000) 20(2):285–286.
  • WHALLEY LJ, BLAIN PG, PRIME JK: Haloperidol secreted in breast milk. Br. Med. J. (Clin Res(1981) 282(6278):1746–1747.
  • STEWART RB, KARAS B, SPRINGER PK: Haloperidol excretion in human milk. Am. I Psychiatry (1980) 137(7):849–850.
  • LEE A, GIESBRECHT E, DUNN E, ITO S: Excretion of quetiapine in breast milk. Am. J. Psychiatry (2004) 161(9):1715–1716.
  • MORETTI ME, KOREN G, VERJEE Z, ITO S: Monitoring lithium in breast milk: An individualized approach for breast-feeding mothers. Therap. Drug Monk (2003) 25(3):364–366.
  • •Rational approach to the difficult problem of dealing with lithium therapy and breastfeeding.
  • KOREN G, MORETTI M, ITO S: Continuing drug therapy while breastfeeding - Part 2.Common misconceptions of physicians. Can. Fam. Physician. (1999) 45:1173.
  • YOSHIDA K, MARKS MN, CRAGGS M, SMITH B, KUMAR R: Sensorimotor and cognitive development of infants of mothers with schizophrenia. BE I Psychiatry (1999) 175:380-7:380–387.
  • VAN LIEBURG AF, MONNENS LA: Kidney insufficiency and persistent hypotension following compromise of the renin-angiotensin system in a fetus and a young infant. Ned. Tfidschr. Ceneeskd. (2001) 145(14):695–698.
  • BEGG EJ, ROBSON RA, GARDINER SJ et al.: Quinapril and its metabolite quinaprilat in human milk. BE I Clin. Pharmacol (2001) 51(5):478–481.
  • DEVLIN RG, FLEISS PM: Captopril in human blood and breast milk. Pharmacol (1981) 21(2):110–113.
  • REDMAN CW, KELLY JG, COOPER WD: The excretion of enalapril and enalaprilat in human breast milk. Eur.Pharmacol (1990) 38(1):99.
  • EHRENKRANZ RA, ACKERMAN BA, HULSE JD: Nifedipine transfer into human milk. J. Pediatr. (1989) 114(3):478–480.
  • MANNINEN AK, JUHAKOSKI A: Nifedipine concentrations in maternal and umbilical serum, amniotic fluid, breast milk and urine of mothers and offspring. Int. Pharmacol Res. (1991) 11(5):231–236.
  • PENNY WJ, LEWIS MJ: Nifedipine is excreted in human milk. Eur. Pharmacol (1989) 36(4):427–428.
  • MILLER MR, WITHERS R, BHAMRA R, HOLT DW: Verapamil and breast-feeding. Eur.Pharmacol (1986) 30(1):125–126.
  • ANDERSON P, BONDESSON U, MATTIASSON I, JOHANSSON BW: Verapamil and norverapamil in plasma and breast milk during breast feeding. Eur. Clin. Pharmacol (1987) 31(5):625–627.
  • INOUE H, UNNO N, OU MC, IWAMA Y, SUGIMOTO T: Level of verapamil in human milk [letter]. Eur. Clin. Pharmacol (1984) 26(5):657–658.
  • OKADA M, INOUE H, NAKAMURA Y, KISHIMOTO M, SUZUKI T: Excretion of diltiazem in human milk [letter]. New Engl. J. Med. (1985) 312(15):992–993.
  • BOUTROY MJ, BIANCHETTI G, DUBRUC C, VERT P, MORSELLI PL: To nurse when receiving acebutolol: is it dangerous for the neonate? Eur. Clin. Pharmacol (1986) 30(6):737–739.
  • SCHIMMEL MS, EIDELMAN Al, WILSCHANSKI MA et al.: Toxic effects of atenolol consumed during breast feeding [published erratum appears in J. Pediatr. (1990) 116(1):158 [see comments]. Pediatr. (1989) 114(3):476–478.
  • SMITH MT, LIVINGSTONE I, HOOPER WD, EADIE MJ, TRIGGS EJ: Propranolol, propranolol glucuronide, and naphthoxylactic acid in breast milk and plasma. Therap. Drug Monit. (1983) 5W:87–93.
  • SANDSTROM B, REGARDH CG: Metoprolol excretion into breast milk. Br. J. Chit. Pharmacol (1980) 9(5):518–519.
  • WHITE WB, ANDREOLI JW, WONG SH, COHN RD: Atenolol in human plasma and breast milk. Obstet. Cynecol. (1984) 63(3 Suppl.):425–445.
  • THORLEY KJ, MCAINSH J: Levels of the beta-blockers atenolol and propranolol in the breast milk of women treated for hypertension in pregnancy. Biopharm. Drug Dispos. (1983) 4(3):299–301.
  • KULAS J, LUNELL NO, ROSING U, STEEN B, RANE A: Atenolol and metoprolol. A comparison of their excretion into human breast milk. Acta Obstet. Cynecol. Scand. Suppl. (1984) 118:65-9:65–69.
  • LUNELL NO, KULAS J, RANE A: Transfer of labetalol into amniotic fluid and breast milk in lactating women. Eur. Clin. Pharmacol (1985) 28(5):597–599.
  • PK IN PREGNANCY WORKING GROUP OF THE PREGNANCY LABELING TASK FORCE: Guidance for industry. Clinical lactation studies - study design, data analysis, and recommendations for labeling. Draft February 2005.ht01/ www.fda.gov/cder/guidancehndex.htm. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) (2005).
  • HAMPTON T: Pediatric drug studies required by law. JAMA. (2004) 291(4):412–413.
  • NORDENG H, HAVNEN GC: Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. Pharmacoepidemiol Drug Sal: (2004) 13(6):371–380.
  • LAWRENCE RA, LAWRENCE RM: Drugs in breast milk. In: Breasdeeding; a guide for the medical profession. Lawrence RA, Lawrence RIVI (Ed.), Mosby, St Louis USA (1999):371–381.
  • HUMPHREY SI, MCKENNA DJ: Herbs and breastfeeding. Breastkeding Abstr. (1997) 17(2):11–12.
  • LEE A, MINHAS R, MATSUDA N, LAM M, ITO S: The safety of St. John's wort (Hypericum perforatum) during breastfeeding. I Clin. Psychiatry (2003) 64(8):966–968.
  • •Good example of an observational study of the effects of a drug that could be transferred into milk.
  • BEGG EJ: In: Clinical Pharmacology Essentials. The Principles Behind the Prescribing Process. Adis International, Auckland (2000):34–35.
  • NEWMAN RG, BASHKOW S, CALKO D: Results of 313 consecutive live births of infants delivered to patients in the New York City Methadone Maintenance Treatment Program. Am. J. Obstet. Cynecol (1975) 121(2):233–237.
  • ANONYMOUS: In: Australian Medicines Handbook. Bochner, F. (Ed.), The Australian Medicines Handbook Pty Ltd, Adelaide, Australia (2005):xviii-xix.
  • HENDRICK V, SMITH LM, SURI R, HWANG S, HAYNES D, ALTSHULER L: Birth outcomes after prenatal exposure to antidepressant medication. Am. J. Obstet. Cynecol (2003) 188(3):812–815.
  • RAMPONO J, PROUD S, HACKETT LP, KRISTENSEN JH, ILETT KF: A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate. Int. Neuropsychopharmacol (2004) 7(3):329–334.
  • ••Highlights the difficulties of interpretationof adverse effects in the crossover between pregnancy and lactation.
  • COSTEI AM, KOZER E, HO T, ITO S, KOREN G: Perinatal outcome following third trimester exposure to paroxetine. Arch. Pediatr: Adolesc. Med. (2002) 156(10:1129–1132.
  • CHAMBERS CD, JOHNSON KA, DICK LM, FELIX RJ, JONES KL: Birth outcomes in pregnant women taking fluoxetine. New Engl. J. Med. (1996) 335(14):1010–1015.
  • HENDRICK V, STOWE ZN, ALTSHULER LL, HWANG S, LEE E, HAYNES D: Placental passage of antidepressant medications. Am. J. Psychiatry (2003) 160(5):993–996.
  • BEGG EJ, DUFFULL SB, SAUNDERS DA et al.: Paroxetine inhuman milk. BE J. Clin. Pharmacol (1999) 48(2):142–147.
  • PLOMP TA, VULSMA T, DE VIJLDER JJ: Use of amiodarone during pregnancy. Eur. I Obstet. Cynecol. Reprod. Biol. (1992) 43(3):201–207.
  • MCKENNA WJ, HARRIS L, ROWLAND E, WHITELAW A, STOREY G, HOLT D: Amiodarone therapy during pregnancy. Am. J. Cardiol (1983) 51(7):1231–1233.
  • STRUNGE P, FRANDSEN J, ANDREASEN F: Amiodarone during pregnancy. Eur. Heart J. (1988) 9(1):106–109.
  • HAVELKA J, FRANKOVA A: Adverse effects of chloramphenicol in newborn infants. Cesk. Pediatr: (1972) 27(1):31–33.
  • KUNII K: Effects of chloramphenicol on the mother and baby. II.Transfer, absorption, excretionandadverse effects of chloramphenicol in the newborn infant. Jap. J. Antibiotics (1970) 23(4):363–378.
  • SMADEL JE, WOOD WARD TE: Chloramphenicol in the treatment of Tsutsugamushi disease. J. Clin. Invest. (1949) 28:1196–1215.
  • MORETTI ME, LEE A, ITO S: Which drugs are contraindicated during breastfeeding? Practice guidelines. Can. Fam. Physician (2000) 46:1753–1757.
  • JOLIVET A, ROBYN C, HURAUX-RENDU C, GAUTRAY JP: Effect of ergotalkaloid derivatives on milk secretion in the immediate postpartum period. I Cyriecol Obstet. Biol. Reprod. (1978) 7(1):129–134.
  • GOGUEL M, NOEL G, GILLET JY: Therapeutique anticoagulnte al allaitement; etude du passage de la pheny1-2-dioxo,13-indane darts le lait maternal. Rev FE Cynecol Obstet. (1990) 65:409–412.
  • ECKSTEIN HB, JACK B: Breast-feeding and anticoagulant therapy. Lancet (1970) 1(7648):672–673.
  • SIOUFI A: Recent findings concerning clinically relevant pharmacokinetics of diclofenac sodium. In: Voltaren-new findings. Kass (Ed.), Hans Huber Publishers, Bern, Switzerland (1982).
  • WEIBERT RT, TOWNSEND RJ, KAISER DG, NAYLOR AJ: Lack of ibuprofen secretion into human milk. Pharm. (1982) 1(5):457–458.
  • TOWNSEND RJ, BENEDETTI TJ, ERICKSON SH et al: Excretion of ibuprofen into breast milk. Am. Obstet. Cynecol (1984) 149(2):184–186.
  • LEBEDEVS TH, WOJNAR-HORTON RE, YAPP P et al.: Excretion of indomethacin in breast milk. BE J. Clin. Pharmacol. (1991) 32(6):751–754.
  • EEG-OLOFSSON 0, MALMROS I, ELWIN CE, STEEN B: Convulsions in a breast-fed infant after maternal indomethacin [letter]. Lancet (1978) 2(8082):215.
  • JAMALI F, STEVENS DR: Naproxen excretion in milk and its uptake by the infant [letter]. Drug. Intell Pharm. (1983) 17(12):910–911.
  • FIGALGO I: Anemia aguda, rectaorragia y hematuria asociadas a la ingestion de naproxen. An. Esp. Pediatr. (1989) 30:317–319.
  • WITTELS B, SCOTT DT, SINATRA RS: Exogenous opioids in human breast milk and acute neonatal neurobehavior: a preliminary study. Anesthesiology (1990) 73(5):864–869.
  • FEILBERG VL, ROSENBORG D, BROEN CC, MOGENSEN JV: Excretion of morphine in human breast milk. Acta. Anaesthesia Scand. (1989) 33(5):426–428.
  • WOJNAR-HORTON RE, KRISTENSEN JH, YAPP P, ILETT KF, DUSCI LJ, HACKETT LP: Methadone distribution and excretion into breast milk of clients in a methadone maintenance programme. BE J. Clin. Pharmacol. (1997) 44(6):543–547.
  • BEGG EJ, MALPAS TJ, HACKETT LP, ILETT KF: Distribution of R- and S-methadone into human milk at steady state during ingestion of medium to high doses. BE I Clin. Pharmacol. (2001) 52:681–685.
  • •Illustrates the differences in milk transfer for enantiomers.
  • GERAGHTY B, GRAHAM EA, LOGAN B, WEISS EL: Methadone levels in breast milk. Hum. Lact. (1997) 13(3):227–230.
  • PEIKER G, MULLER B, IHN W, NOSCHEL H: Excretion of pethidine in mother's milk (author's trans°. Zentralbl. Cynakol (1980) 102(10):537–541.
  • QUINN PG, KUHNERT BR, KAINE CJ, SYRACUSE CD: Measurement of meperidine and normeperidine in human breast milk by selected ion monitoring. Biomed. Environ. Mass Spectrometry (1986) 13(3):133–135.
  • PYNNONEN S, KANTO J, SILLANPAA M, ERKKOLA R: Carbamazepine: placental transport, tissue concentrations in foetus and newborn, and level in milk. Acta Pharmacol. Toxica (Copenh). (1977) 41(3):244–253.
  • SHIMOYAMA R, OHKUBO T, SUGAWARA K: Monitoring of carbamazepine and carbamazepine 10,11-epoxide in breast milk and plasma by high-performance Liquid chromatography. Annals Clin. Biochem. (2000) 37:210–215.
  • STEEN B, RANE A, LONNERHOLM G, FALK 0, ELWIN CE, SJOQVIST F: Phenytoin excretion in human breast milk and plasma levels in nursed infants. Therap. Drug Monit. (1982) 4(4):331–334.
  • VON UNRUH GE, FROESCHER W, HOFFMANN F, NIESEN M: Valproic acid in breast milk: how much is really there? Therap. Drug Monit. (1984) 6(3):272–276.
  • NAU H, KUHNZ W, EGGER HJ, RATING D, HELGE H: Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics. Clin. Pharmacokinet. (1982) 7(6):508–543.
  • TOMSON T, OHMAN I, VITOLS S: Lamotrigine in pregnancy and lactation: a case report. Epilepsia. (1997) 38(9):1039–1041.
  • RAMBECK B, KURLEMANN G, STODIECK SR, MAY TW, JURGENS U: Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child. Eur.Pharmacol. (1997)51(6):481–484.
  • WRETLIND M: Excretion of oxazepam in breast milk. Eur.Pharmacol. (1987)33(2):209–210.
  • WOJNAR-HORTON RE, HACKETT LP, YAPP P, DUSCI LJ, PAECH M, ILETT KF: Distribution and excretion of sumatriptan in human milk. BE I Clin. Pharmacol. (1996) 41(3):217–221.
  • KNOWLES JA: Drugs in milk. Pediatric Currents (1972) 21:28–32.
  • KELSEY JJ, MOSER LR, JENNINGS JC, MUNGER MA: Presence of azithromycin breast milk concentrations: a case report. Am. I Obstet. Cynecol. (1994) 170(5 Pt 1):1375–1376.
  • GIAMARELLOU H, KOLOKYTHAS E, PETRIKKOS G, GAZIS J, ARAVANTINOS D, SFIKAKIS P: Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am. Med. (1989) 87(5A):495–515.
  • GARDNER DK, GABBE SG, HARTER C: Simultaneous concentrations of ciprofloxacin in breast milk and in serum in mother and breast-fed infant. Clin. Pharm. (1992) 11(0352–354.
  • WISE R: Norfloxacin-a review of pharmacology and tissue penetration. Antimicrob. Chemother. (1984) 13(Suppl. B):59–64.
  • NOROXIN PRODUCT INFORMATION. In: E-MIMS Ver 5.00.0106. MultiMedia Australia Pty Limited, St Leonards, Australia (2005).
  • SMITH JA, MORGAN JR: Clindamycin in human breast milk. Can. Med. Ass. J. (1975) 112:806.
  • MANN CF: Clindamycin and breast-feeding [letter]. Pediatrics. (1980) 66(6):1030–1031.
  • MORGANTI G, CECCARELLI G, CIAFFI G: Comparative concentrations of atetracycline antibiotic in serum and maternal milk. AM/Not/ea (1968) 6(3):216–223.
  • PASSMORE CM, MCELNAY JC, RAINEY EA, D'ARCY PF: Metronidazole excretion in human milk and its effect on the suckling neonate. Br. J. Clin. Pharmacol (1988) 26(1):45–51.
  • HEISTERBERG L, BRANEBJERG PE: Blood and milk concentrations of metronidazole in mothers and infants. Perinal Med. (1983) 11(2):114–120.
  • ERICKSON SH, OPPENHEIM GL, SMITH GH: Metronidazole in breast milk. Obstet. Cynecol (1981) 57(1):48–50.
  • REYES MP, OSTREA EMJ, CABINIAN AE, SCHMITT C, RINTELMANN W: Vancomycin during pregnancy: does it cause hearing loss or nephrotoxicity in the infant? [see comments]. Am. Obstet. Cynecol (1989) 161(4):977–981.
  • FORCE RW: Fluconazole concentrations in breast milk. Pediatr. Infect. Dis. (1995) 14(3):235–236.
  • SHEFFIELD JS, FISH DN, HOLLIER LM, CADEMATORI S, NOBLES BJ, WENDEL GD: Acyclovir concentrations in human breast milk after valaciclovir administration. Am. J. Obstet. Cynecol (2002) 186(1):100–102.
  • JOHANSEN K, ANDERSEN AN, KAMPMANN JP, MOLHOLM HJ, MORTENSEN HB: Excretion of methimazole in human milk. Eur. Clin. Pharmacol (1982) 23(4):339–341.
  • KATZ FH, DUNCAN BR: Letter: Entry of prednisone into human milk. New Engl. J. Med. (1975) 293(22):1154.
  • MCKENZIE SA, SELLEY JA, AGNEW JE: Secretion of prednisolone into breast milk. Arch. Dis. Child. (1975) 50(11):894–896.
  • BRIGGS GG, SAMSON JH, AMBROSE PJ, SCHROEDER DH: Excretion of bupropion in breast milk. Annals Pharmacother. (1993) 27(4):431–433.
  • SCHMIDT K, OLESEN OV, JENSEN PN: Citalopram and breast-feeding: serum concentration and side effects in the infant. Biol. Psychiatry (2000) 47(2):164–165.
  • JENSEN PN, OLESEN OV, BERTELSEN A, LINNET K: Citalopram and desmethylcitalopram concentrations in breast milk and in serum of mother and infant. Therap. Drug Monit. (1997) 19(2):236–239.
  • OHMAN R, NORSTEDT B, VITOLS WS: Citalopram and metabolite levels in plasma and breast milk in two nursing women. BE J. Clin. Pharmacol (1997) :A179.
  • SPIGSET 0, CARIEBORG L, OHMAN R, NORSTROM A: Excretion of citalopram in breast milk. Br.Pharmacol (1997) 44(3):295–298.
  • NORDENG H, BERGSHOLM YK, BOHLER E, SPIGSET 0: Excretion of selective serotonin reuptake inhibitors in breast milk. Tidsskr. Nor. Laegeforen. (2001) 121(2):199–203.
  • FISH EW, FACCIDOMO S, GUPTA S, MICZEK KA: Anxiolytic-like effects of escitalopram, citalopram and R- citalopram in maternally separated mouse pups. Pharmacol Exp. Ther. (2003)
  • TADDIO A, ITO S, KOREN G: Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk. Pharmacol (1996) 36(1):42–47.
  • ISENBERG KE: Excretion of fluoxetine in human breast milk [letter]./. Psychiatry (1990) 51(4):169.
  • BRENT NB, WISNER KL: Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair. Clin. Pediat. (Phila.). (1998) 37(1):41–44.
  • HENDRICK V, STOWE ZN, ALTSHULER LL et al: Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk. Biol. Psychiatry (2001) 50(10):775–782.
  • YOSHIDA K, SMITH B, CRAGGS M, KUMAR RC: Fluoxetine in breast-milk and developmental outcome of breast-fed infants [seecomments]. Br. Psychiatry (1998) 172:175-8:175–178.
  • BURCH KJ, WELLS BG: Fluoxetine/ norfluoxetine concentrations in human milk. Pediatrics (1992) 89(4 Pt 1):676–677.
  • KRISTENSEN JH, HACKETT LP, KOHAN R, PAECH MJ, ILETT KF: The amount of fluvoxamine in milk is unlikely to be a cause of adverse effects in breastfed infants. Hum. Lact. (2001) 18:139–143.
  • WRIGHT S, DAWLING S, ASHFORD JJ: Excretion of fluvoxamine in breast milk. BE J. Clin. Pharmacol (1991) 31:209.
  • HAGG S, GRANBERG K, CARLEBORG L: Excretion of fluvoxamine into breast milk. BE J. Clin. Pharmacol (2000) 49(3):286–288.
  • ARNOLD LM, SUCKOW RE LICHTENSTEIN PK: Fluvoxamine concentrations in breast milk and in maternal and infant sera. I Clin. Psychopharmacol (2000) 20(4):491–493.
  • YOSHIDA K, SMITH B, CHANNIKUMAR R: Fluvoxamine in breast-milk and infant development. Br. J. Clin. Pharmacol (1997) 44:210–211.
  • PIONTEK CM, WISNER KL, PEREL JM, PEINDL KS: Serum fluvoxamine levels in breastfed infants. Clin. Psychiatry (2001) 62(2):111–113.
  • ILETT KF, HACKETT LP, KRISTENSEN JH, RAMP ONO J: Distribution and excretion of the novel antidepressant mirtazapine in human milk. 2003 Conference and Annual Meeting of the International Lactation Consultant Association. Sydney, Australia (2003).
  • MISRI S, KIM J, RIGGS KW, KOSTARAS X: Paroxetine levels in postpartum depressed women, breast milk, and infant serum. I Clin. Psychiatry (2000) 61(11):828–832.
  • STOWE ZN, COHEN LS, HOSTETTER A, RITCHIE JC, OWENS MJ, NEMEROFF CB: Paroxetine in human breast milk and nursing infants. Am. I Psychiatry (2000) 157(2):185–189.
  • BLACKER KH: Mothers milk and chlorpromazine. Am. I Psychiatry (1962) 114:178–179.
  • WILES DH, ORR MW, KOLAKOWSKA T: Chlorpromazine levels in plasma and milk of nursing mothers. BE Clin. Pharmacol (1978) 5(3):272–273.
  • LLEWELLYN A, STOWE ZN, STRADER JRJ: The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J. Clin. Psychiatry (1998) 59\(Suppl. 6):57–64.
  • SCHOU M, AMDISEN A: Lithium and pregnancy. 3.Lithium ingestion by children breast-fed by women on lithium treatment. Br. Med. J. (1973) 2(859):138.
  • AMBRESIN G, BERNEY P, SCHULZ P, BRYOIS C: Olanzapine excretion into breast milk: a case report. J. Psychopharmacol (2004) 24(1):93–95.
  • LEE A, GIESBRECHT E, DUNN E, ITO S: Excretion of quetiapine in breast milk. Am. I Psychiatry (2004) 161(9):1715–1716.

Websites

  • hdp://www.breastfeedingonline.com/ DomperidoneFDATranscript.shtml. CURTIS C: Unofficial, but accurate, transcript of the FDA domperidone (2004).
  • http://www.fda.gov/bbs/topics/ANSWERS/ 192004/ANS01292.html ANONYMOUS: FDA warns against women using unapproved drug, domperidone, to increase milk production (2004).
  • http://neonatal.ama.ttuhsc.edu. HALE T W: FDA warning on domperidone (2004).
  • http://www.iacprx.org. INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS: Issue brief: domperidone (2004).
  • http://www.bfacorg. SMILLIE CM: Letter to FDA re domperidone (2004).
  • http://breastfeedingonline.com NEWMAN J, GORDON J, NICE F J: Official statements from prominent physicians (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.